OS Therapies OSTX Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period at other companies

USCB Financial Holdings, Inc.USCB

0-100%

Playtika Holding Corp.PLTK

100K—

Ondas, Inc. ONDS

458.3K+1,401%

First Seacoast BancorpFSEA

2.8K-72.5%

TRV

Trevi Therapeutics, Inc.TRVI

331.2K+394%

QuidelOrtho CorporationQDEL

521K—

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's share-based compensation arrangement by share-based payment award, options, forfeitures in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's share-based compensation arrangement by share-based payment award, options, forfeitures in period?: OS Therapies (OSTX) reported share-based compensation arrangement by share-based payment award, options, forfeitures in period of 463.8K in Q1 2026.